World Congress on Brain, Behavior and Emotions (Brain 2014). The scientific program will focus on linking basic neuroscience and clinical applications in several specialties from neurology, psychiatry, neurosurgery, neuropsychology, psychology, and geriatrics, to sleep and basic neuroscience. Visit the website for more information
April 10-11, 2014 - San Francisco.
The Neurobiology of Pain and Itch is taking place in San Francisco on April 10-11, 2014 and is chaired by Allan Basbaum (UCSF) and David Julius (UCSF). There are still opportunities to present available.
Meeting Topics include:
Molecular heterogeneity of the primary afferent: a target for pain therapy
Unraveling the dorsal horn circuits that transmit pain messages
Distinguishing the neural circuits that cause itch from those that cause pain
Imaging the brain: where pain and itch percepts are ultimately generated
The Department of Physiology at University of Toronto invites all members of its community to attend a cocktail reception for alumni and friends during the upcoming Canadian Neuroscience Meeting. Join us for an opportunity to reconnect with former classmates and colleagues.
Location: Belvédère Room, Hilton Bonaventure Hotel, Montreal
May 29th - 30th 2014, Edmonton AB
Shedding New Light on Monoaminergic Signaling and Neuropsychiatric Disorders.
8th Annual Frontiers in Neurophotonics Summer School. The Frontiers in Neurophotonics Summer School is a unique
opportunity to learn how to use advanced optical methods for your
research. It consists of morning lectures on the theoretical basis of the use of light, optics and probes to study brain cells (both ex– and in-vivo), followed by afternoons dedicated to hands-on experiments on custom microscopes.
Go to the Neurophotonics Summer school website for more details
July 13-15th, 2014, Prince Edward Island, Canada
Biotechnology & Human Health Symposium 2014, Featuring:
- Discussions of the newest therapeutic approaches in neuroprotection and repair
- Attended by leading business, research, clinical and investment professionals within neuroscience
- One-to-One Partnering Program
- Great Island hospitality and culinary delights
For more information on the conference, visit http://www.biotechnologyandhumanhealth.com/
July 26-31, 2014, Québec City, Canada
23rd Annual Meeting of the Organization for Computational Neurosciences (OCNS)
The main meeting (July 27 – 29) will be preceded by a day of
tutorials (July 26) and followed by two days of workshops (July 30 –31).
Invited Keynote Speakers:
Chris Eliasmith, University of Waterloo, Canada
Christof Koch, Allen Institute for Brain Science,USA
Henry Markram, EPFL Lausanne, Switzerland
Frances Skinner, TWRI/UHN, University of Toronto, Canada
For up-to-date conference information, please visit
OCNS is the international member-based society for computational
neuroscientists. Become a member to be eligible for travel awards and more.
August 3 - 17, 2014 - Minneapolis, MN
Fourth Annual Computational Sensory-Motor Neuroscience Summer School (CoSMo 2014)
University of Minnesota
The course is about experimental, computational and medical aspects of sensory-motor neuroscience with a focus on data/model sharing. Covered topics include Bayesian approaches, motor control, computational neuroimaging, sensory-motor transformations and prosthetics.
The course is aimed at students and post-doctoral fellows from diverse backgrounds including Life Sciences, Psychology, Computer Science, Physics, Mathematics and Engineering. Basic knowledge in calculus, linear algebra and Matlab is expected. Enrollment will be limited to 40 trainees.
The school is co-organized by Drs Gunnar Blohm, Paul Schrater and Konrad Körding. It receives funding from the National Sciences and Engineering Research Council of Canada (NSERC) via an NSERC-CREATE training grant on "Computational Approaches in Neuroscience – Action, Control & Transformations", and from the National Science Foundation (NSF, USA).
September 4 - 7, 2014, Basel, Switzerland
The World Congress on NeuroTherapeutics: Dilemmas, Debates & Discussions (DDDN)
October 23-25, 2014, The Sheraton Vancouver Wall Centre Hotel
9th International Conference on Frontotemporal Dementias
The ICFTD is the only regularly scheduled international conference devoted to frontotemporal dementia (FTD), making it an important opportunity for FTD clinicians, researchers, trainees and caregivers from around the world to share knowledge with the goal of improving care for patients with this devastating neurodegenerative disease. Visit the conference website: www.ftdvancouver2014.com/, or download the advertisement.
Spring 2014 Newsletter!
Our most recent newsletter includes the list of trainees who were awarded a travel award for the Montreal meeting and more! Read it now: CAN Connection - Spring 2014
Canadian Neuroscience Meeting 2014
Our next meeting will take place May 25 - 28 2014 in Montreal
Thank you for making the CAN Social at the Hard Rock Hotel in San Diego a great get-together once again this year.
We were also happy to meet many of you in person at our exhibit booth at SfN, and look forward to seeing you next in Montreal!
CAN invites its members to thank Air France
Air France's commitment to supporting biomedical research is to be commended. Their continued commitment to transporting live animals used for research is very important to neuroscientists.
We invite all our members and neuroscientists everywhere to write to Air France to thank them for this important support. Read more here
Shayna Rosenbaum 2013 CAN Young Investigator Awardee
The Canadian Association for Neuroscience is proud to announce Dr. Shayna Rosenbaum, from York University, is the CAN 2013 Young Investigator Awardee.
Read Dr. Shayna Rosenbaum's profile and find representative publications on the 2013 Award page.
Neuroscience in the Media
Have you listened to the "Think about it: A user's guide to the brain" radio series this Summer on the CBC? All shows are still available: Think about it website
Read "A Big Brainstorm is underway in Neuroscience", by Ivan Semeniuk, in the Globe and Mail (includes interviews with CAN members David Kaplan, Tim Murphy and Yves De Koninck).
Also on the CBC, Henry Friensen Prize winner Marc Tessier Lavigne was interviewed by Paul Kennedy, host of Ideas. Listen to Building Brains.
The page currently features new funding opportunities from :
Brain Canada - Platform Support Grants
The W. Garfield Weston Foundation
2013 Rapid Response:
Neurodegenerative Diseases of Aging grant program, and the
International Foundation for Research in Paraplegia.
CAN President Feature Interview
Sam David, President of the Canadian Association for Neuroscience, has given a feature interview for the magazine International Innovation.
"International Innovation is the leading global dissemination resource for the wider scientific, technology and research communities, dedicated to disseminating the latest science, research and technological innovations on a global level. More information and a complimentary subscription offer to the publication can be found here"
There are usually three main tools for fighting brain cancer: surgery, radiation and chemotherapy. But for patients with ependymoma, a type of childhood brain tumour most common in babies, despite many clinical trials none of the standard chemotherapy medicines have been shown to help. While treatments for many other childhood cancers have changed and improved over the past two decades, chemotherapy for ependymoma has remained stagnant. The underlying cause of the chemo-resistance has baffled doctors until now. +++ »
More detailed scans could lead to better diagnosis and treatments
Multiple sclerosis (MS) is an unpredictable and debilitating neurodegenerative disease that affects an estimated 100,000 Canadians. Typically, Magnetic Resonance Imaging (MRI) is used to confirm diagnosis, but current techniques are limited in their ability to detect subtle differences in tissue damage. +++ »
Research from Western University (London, Canada) has revealed a possible new target for treating movement disorders such as Huntington’s disease (HD) and Parkinson’s disease. Stephen Ferguson, PhD, a scientist at Western’s Robarts Research Institute, and Fabiola Ribeiro, PhD, of the Universidade Federal de Minas Gerais in Brazil found a definite improvement in motor behaviours in a HD mouse model when one of the major receptors in the brain, called Metabotropic Glutamate Receptor 5 (mGluR5) was deleted. The research is published online in Human Molecular Genetics. +++ »
Study sheds light on why diet may help control seizures in epilepsy patients
A new study by scientists at McGill University and the University of Zurich shows a direct link between metabolism in brain cells and their ability to signal information. The research may explain why the seizures of many epilepsy patients can be controlled by a specially formulated diet. +++ »
Through a series of studies, Dr. Andréa LeBlanc, a principal investigator at the Lady Davis Institute at the Jewish General Hospital, has discovered elevated levels of the protein Caspase-6 in the area of the brain – namely, the hippocampus, which is responsible for memory and cognition – first damaged by Alzheimer’s disease. This phenomenon is seen from the very earliest stages of cognitive impairment. +++ »
New study sheds light on most common and deadly form of brain cancer
Glioblastoma (GBM) is the most common and deadly form of primary malignant brain cancer accounting for approximately 15% of all brain tumours and occurring mostly in adults between the ages of 45 and 70. The aggressive recurrent nature of this cancer is only temporarily contained by combined surgery, chemotherapy and radiation treatment. The recurrence of GBM is usually fatal, resulting in an average patient survival time of less than two years. A new study from the Montreal Neurological Institute and Hospital – The Neuro – at McGill University, published in Nature Communications, identifies two specific key players in the growth of GBM. +++ »